Addressing the burden of respiratory disease in General Practice: A real-life implementation study focusing on high risk asthma and COPD patients

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/38200
• EU PAS number:
  EUPAS38199
• Study ID:
  38200
• Official title and acronym:
  Addressing the burden of respiratory disease in General Practice: A real-life implementation study focusing on high risk asthma and COPD patients
• DARWIN EU® study:
  No
• Study countries:
  Australia
• Study description:
  To identify high-risk asthma and COPD patients and reduce subsequent avoidable hospitalisations through a focused approach on the prevention of frequent disease flare-ups (exacerbations) and improved management of chronic and complex health conditions, associated with preventable factors.
• Study status:
  Planned

Research institutions and networks

Institutions

Woolcock Institute of Medical Research

Networks

Optimum Patient Care (OPC) Network

United Kingdom (Northern Ireland)

Study timelines

Date when funding contract was signed

Planned: 16/11/2020

Study start date

Planned: 01/02/2021

Date of final study report

Planned: 28/02/2023

Sources of funding

Pharmaceutical company and other private sector 

Other

More details on funding

GSK, Observational Pragmatic Research Institute

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable